References
- Packard C J, Shepherd J. The hepatobiliary axis and lipoprotein metabolism: effect of bile acid sequestrants and ileal bypass surgery. J Lipid Res 1971; 12: 233–47
- Angelin B, Einarsson K. Bile acids and lipoprotein metabolism. Atheroscler Rev 1986; 15: 41–66
- Angelin B. Regulation of hepatic cholesterol metabolism in man: influence of genes, age and hormones. Eur J Clin Invest
- Nestel P J, Grundy S M. Changes in plasma triglyceride metabolism during withdrawal of bile. Metabolism 1976; 25: 1591–9
- Angelin B, Einarsson K, Hellstrom K, Leijd B. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. J Lipid Res 1978; 19: 1017–24
- Beil U, Crouse J R, Einarsson K, Grundy S M. Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density lipoprotein triglycerides. Metabolism 1982; 31: 438–44
- Angelin B, Leijd B, Hultcrantz R, Einarsson K. Increased turnover of very low density lipoprotein triglyceride during treatment with cholestyramine in familial hypercholesterolaemia. J Intern Med 1990; 227: 201–6
- Begemann F. Influence of chenodeoxycholic acid on the kinetics of endogenous triglyceride transport in man. Eur J Clin Invest 1978; 8: 283–8
- Angelin B, Leijd B. Effects of cholic acid on the metabolism of endogenous plasma triglyceride and on biliary lipid composition in hyperlipoproteinemia. J Lipid Res 1980; 21: 1–9
- Angelin B, Nilsell K, Einarsson K. Ursodeoxycholic acid treatment in humans: effects on plasma and biliary lipid metabolism, with special reference to very low density lipoprotein triglyceride and bile acid kinetics. Eur J Clin Invest 1986; 16: 169–77
- Reihnér E, Björkhem I, Angelin B, Ewerth S, Einarsson K. Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7α-hydroxylase activity. Gastroenterology 1989; 97: 1498–505
- Leijd B, Angelin B. Effects of chenodeoxycholic acid and cholic acid feeding on plasma lipoproteins and cholesterol absorption in hyperlipoproteinemia: a crossover study. Bile acids and cholesterol in health and disease, G Paumgartner, A Stiehl, W Gerok. MTP Press, LancasterUK 1983; 191–201
- Albers J J, Grundy S M, Cleary P A, Small D M, Lachin J M, Schoenfield L J. National Cooperative Gallstone Study: the effect of chenodeoxycholic acid on lipoproteins and apolipoproteins. Gastroenterology 1982; 82: 638–46
- Rudling M, Reihnér E, Einarsson K, Ewerth S, Angelin B. Low density lipoprotein receptor binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo. Proc Natl Acad Sci USA 1990; 87: 3469–73
- Reihnér E, Angelin B, Rudling M, Ewerth S, Björkhem I, Einarsson K. Regulation of hepatic cholesterol metabolism in man: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J Lipid Res 1990; 31: 2219–26
- Shepherd J, Packard C J, Bicker S, Lawrie T DV, Morgan H G. Cholestyramine promotes receptor-mediated low-density lipoprotein catabolism. N Engl J Med 1980; 302: 1219–22
- Spengel F A, Jadhav A A, Duffield R GM, Wood C B, Thompson G R. Superiority of partial ileal bypass over cholestyramine in reducing cholesterol in familial hypercholesterolaemia. Lancet 1981; 2: 768–70
- Nilsell K, Angelin B, Leijd B, Einarsson K. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis. Gastroenterology 1983; 85: 1248–56
- Eusufzai S, Ericsson S, Cederlund T, Einarsson K, Angelin B. Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test. Gut 1991; 32: 1044–8
- Poupon R E, Ouguerram K, Chrétien Y, Verneau C, Eschwege E, Magot T, Poupon R. Cholesterol-lowering effect of ursodeoxycholic acid in patients with biliary cirrhosis. Hepatology 1993; 17: 577–82